Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen

Volume: 324, Pages: 242 - 248
Published: Feb 1, 2021
Abstract
BackgroundHydroxychloroquine (HCQ) and azithromycin (AZT) have been proposed for COVID-19 treatment. Data available in the literature reported a potential increased risk of fatal arrhythmias under these therapies. The aim of this study was to assess the effects of these drugs on QT interval and outcome in a COVID-19 population.MethodA total of 112 consecutive COVID-19 patients were included in this analysis and were divided in 3 groups according...
Paper Details
Title
Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen
Published Date
Feb 1, 2021
Volume
324
Pages
242 - 248
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.